# A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic

Study · id `cardio:ct-nct01462877` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01462877](<https://clinicaltrials.gov/study/NCT01462877>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01462877

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 506 participants.

## Technical summary

Registry record NCT01462877. Allocation not applicable; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2014-02 (actual). Results posted on 2015-02-23.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 506 participants (enrolled count; ClinicalTrials.gov record NCT01462877, source copy `cardio:ctgov-nct01462877-2015-03-17`, retrieved 2026-10-31)
- Start date: 2011-10 (registry gives no type) (ClinicalTrials.gov record NCT01462877, source copy `cardio:ctgov-nct01462877-2015-03-17`, retrieved 2026-10-31)
- Primary completion: 2014-02 (actual) (ClinicalTrials.gov record NCT01462877, source copy `cardio:ctgov-nct01462877-2015-03-17`, retrieved 2026-10-31)
- Completion: 2014-03 (actual) (ClinicalTrials.gov record NCT01462877, source copy `cardio:ctgov-nct01462877-2015-03-17`, retrieved 2026-10-31)
- Results first posted: 2015-02-23 (ClinicalTrials.gov record NCT01462877, source copy `cardio:ctgov-nct01462877-2015-03-17`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT01462877, source copy `cardio:ctgov-nct01462877-2015-03-17`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01462877-2015-03-17`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic
- Condition: Dyslipidemias
- Condition: Cardiovascular Diseases
- Condition: Hypertriglyceridemia
- Intervention (Drug): fenofibrate
- Lead sponsor: Abbott
- Lead sponsor class: INDUSTRY
- Collaborator: Rundo International Pharmaceutical Research & Development Co.,Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High triglycerides (`cardio:hypertriglyceridemia`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: 1fd022dda2f8092ea4d01951a5d937a94b123ab5e3431c94b98f6bbe0b03323d
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
